220 Biotech Companies to Present at International BIO 2002 Business Forum
The 230 companies, listed below, will describe their technologies, products and business plans during 15-minute presentations, which will be grouped according to technology in three simultaneous tracks. In addition to the presentations, BIO has scheduled more than 1,000 separate meetings between featured companies and potential partners and investors.
“The Business Forum will provide an opportunity for investors and pharmaceutical executives to evaluate early-stage companies with promising new technologies and products, as well as mid- and late-stage companies that have products in advanced testing,” said Morrie Ruffin, BIO’s vice president for business development and emerging companies.
The 12 countries represented in the Business Forum are Australia, Austria, Canada, Denmark, Finland, France, Germany, Israel, the Netherlands, Switzerland, the United Kingdom and the United States.
BIO 2002 registration for approved, credentialed media is complimentary, and advance registration is encouraged. All freelancers must register in advance. To register please visit www.bio.org. In order to ensure housing, reporters are urged to register as soon as possible.
BIO represents more than 1,000 biotechnology companies, academic institutions,
state biotechnology centers and related organizations in all 50 U.S. states and 33 other nations. BIO members are involved in the research and development of health-care, agricultural, industrial and environmental biotechnology products.
BIO 2002 Business Forum Presenting Companies
| Canada Active Pass Pharmaceuticals Aegera Therapeutics Inc. Aterna Laboratories Inc. Affinium Pharmaceuticals Angiongene Inc. Angiotech Pharmaceuticals Inc. AnorMED Inc. Arius Research, Inc. Axcan Pharma Inc. Biomira Inc. Bioniche Life Sciences Inc. Biovail Pharmaceuticals Inc. Caprion Pharmaceuticals Inc. Celator Technologies Inc. Celmed Biosciences Inc. Chromos Molecular Systems Inc. Chronogen Inc. ConjuChem Inc. Cytochroma Inc. Cytovax Biotechnologies Inc. Delex Therapeutics Inc. Diabetogen Biosciences Inc. Gemin X Biotechnologies Inc. Generex Biotechnology Corp. GlycoDesign Inc. Hemosol Inc. IatroQuest Corporation IMI International Medical Innovations Inc. Inex Pharmaceuticals Corporation Inflazyme Pharmaceuticals Ltd. Isotechnika Inc. Kinetek Pharmaceuticals, Inc. Labopharm Inc. Lorus Therapeutics Inc. MDS Inc. MDS Proteomics Inc. Medicago Inc. MethylGene Inc. Micrologix Biotech Inc. Molecular Mining Corporation Neurochem Inc. NeuroMed Technologies Inc. Origenix Technologies Inc. PhageTech Inc. ProMetic Life Sciences Inc. QLT Inc. SemBioSys Genetics Inc. Syn-X Pharma Inc. TGN Biotech Inc. Transition Therapeutics Inc. Vasogen Inc. Viron Therapeutics Inc. Viventia Biotech Inc. VSM MedTech Ltd. Xenon Genetics Inc. Xillix Technologies Corp. Australia Austria Denmark Finland Germany Switzerland United Kingdom | United States Achillion Pharmaceuticals, Inc. Acusphere, Inc. Aderis Pharmaceuticals, Inc. Advanced Life Sciences Agensys, Inc. Albany Molecular Research, Inc. Allos Therapeutics, Inc. Anadys Pharmaceuticals, Inc. Applied Molecular Evolution, Inc. Ardais Corporation Ardent Pharmaceuticals, Inc. Array BioPharma Inc. Athersys, Inc. AVANT Immunotherapeutics, Inc. BattellePharma, Inc. Beyond Genomics, Inc. Biolex, Inc. BioMedicines BioTransplant Incorporated Cell Genesys, Inc. Cepheid CEPTYR, Inc. Cetek Corporation ChemoCentryx, Inc. Corvas International, Inc. CuraGen Corporation Cytokinetics, Inc. Deltagen, Inc. Dendreon Corporation DepoMed, Inc. DOR BioPharma, Inc. DrugAbuse Sciences, Inc. Dyax Corp. Elixir Pharmaceuticals, Inc. EntreMed, Inc. Epicyte Pharmaceutical, Inc. Epimmune Inc. EPIX Medical, Inc. eXegenics Inc. ExonHit Therapeutics Inc. FibroGen, Inc. First Genetic Trust, Inc. Genaissance Pharmaceuticals, Inc. GeneFormatics Incorporated Genelabs Technologies, Inc. Genencor International, Inc. GenStar Therapeutics Corporation Genta Incorporated Genzyme Transgenics Corporation GlycoGenesys, Inc. Gryphon Sciences Guilford Pharmaceuticals Inc. Hollis-Eden Pharmaceuticals, Inc. Human Genome Sciences, Inc. Hyseq Pharmaceuticals, Inc. Icagen, Inc. Idun Pharmaceuticals, Inc. Immusol Inhale Therapeutic Systems, Inc. Inhibitex, Inc. InterMune Pharmaceuticals, Inc. Iomai Corporation Isotope Solutions Group, Inc. Koronis Pharmaceuticals, Inc. Lexicon Genetics Incorporated LifePoint, Inc. Ligand Pharmaceuticals Incorporated Locus Discovery Inc. MaxCyte, Inc. MAXIA Pharmaceuticals, Inc. Maxim Pharmaceuticals Inc. Memory Pharmaceuticals Corp. MERIX Bioscience, Inc. Metabasis Therapeutics, Inc. Mojave Therapeutics, Inc. Monoclonal Antibody Therapeutics Inc. Nanogen, Inc. Nephros Therapeutics, Inc. Nereus Pharmaceuticals, Inc. Neurobiological Technologies, Inc. NewBiotics, Inc. Orchid Biosciences, Inc. Nobex Corporation Northwest Biotherapeutics, Inc. Onyx Pharmaceuticals, Inc. Oxigene, Inc. Paratek Pharmaceuticals, Inc. Pharmos Corporation PPL Therapeutics Inc. Protiva Biotherapeutics Inc. PTC Therapeutics, Inc. RenalTech International, LLC Ribozyme Pharmaceuticals, Inc. Ricerca, LLC Sangamo BioSciences, Inc. Sequella, Inc. Stressgen Biotechnologies Corp Structural Bioinformatics Inc. Structural GenomiX, Inc. Targacept, Inc. Target Discovery, Inc. TransMolecular, Inc. Tripos, Inc. Tularik Inc. Valenits Variagenics, Inc. Vical Incorporated XTL Biopharmaceuticals Ltd. ZYCOS Inc. Netherlands |